{"date":"2025-05-15","count":8,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7607-2025-05-15-1737-1pu04cw","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-05-15","time":"17:37:56","subject":"(更正召集事由項次)公告本公司董事會決議召開114年第一次股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-05-15 17:37，「(更正召集事由項次)公告本公司董事會決議召開114年第一次股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-15-1718-127dakp","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-15","time":"17:18:37","subject":"公告本公司現金增資認股基準日等相關事宜(補充發行價格、委託代收及存儲價款機構)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-15 17:18，「公告本公司現金增資認股基準日等相關事宜(補充發行價格、委託代收及存儲價款機構)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-05-15-1701-p67uuk","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-05-15","time":"17:01:30","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-05-15","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-05-15 17:01，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-05-15-1701-i043eu","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-05-15","time":"17:01:08","subject":"公告本公司董事會通過營業地址變更案","clause":"第44款","fact_date":"2025-05-15","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-05-15 17:01，「公告本公司董事會通過營業地址變更案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-05-15-1645-131l4p5","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-05-15","time":"16:45:33","subject":"本公司向美國食品藥物管理局(US FDA)提出申請異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗","clause":"第10款","fact_date":"2025-05-15","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-05-15 16:45，「本公司向美國食品藥物管理局(US FDA)提出申請異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-05-15-1630-k0jtr","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-05-15","time":"16:30:48","subject":"公告本公司脂肪肝炎新藥SNP-610取得日本專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-05-15 16:30，「公告本公司脂肪肝炎新藥SNP-610取得日本專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-05-15-1622-8ib1hj","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-05-15","time":"16:22:20","subject":"本公司114年現金增資收足股款暨增資基準日公告","clause":"第53款","fact_date":"2025-05-15","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-05-15 16:22，「本公司114年現金增資收足股款暨增資基準日公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-15-1511-1exr484","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-15","time":"15:11:08","subject":"本公司有價證券近期股價異常，故公告相關訊息以利投資人區別暸解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-15 15:11，「本公司有價證券近期股價異常，故公告相關訊息以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}